Apollo Stack vs Superman Stack
A side-by-side research comparison of Apollo Stack and Superman Stack across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Apollo Stack | Superman Stack |
|---|---|---|
| Full name | Apollo (Semaglutide + 5-Amino-1MQ + MOTS-c + Tesamorelin) | Superman (CJC-1295 + Ipamorelin + MK-677) |
| Category | Popular Stacks | Popular Stacks |
| Status | Research stack | Research stack |
| Mechanism | Semaglutide activates GLP-1 receptors for appetite/glucose control. 5-Amino-1MQ inhibits NNMT to boost NAD+ and cellular energy. MOTS-c activates AMPK like exercise. Tesamorelin specifically targets visceral fat through GH-mediated lipolysis. | CJC-1295 (no DAC) mimics GHRH for pituitary stimulation. Ipamorelin acts as a selective ghrelin receptor agonist for GH release without cortisol/prolactin. MK-677 provides oral, long-acting ghrelin mimetic action for sustained IGF-1 elevation. |
| Molecular weight | Multiple compounds | Multiple compounds |
| Half-life | Semaglutide: ~7 days, 5A1MQ: ~6h, MOTS-c: ~4h, Tesamorelin: ~30min | CJC: ~30min, Ipamorelin: ~2h, MK-677: ~24h |
| Bioavailability | Variable by component | CJC/Ipa: ~95% SC, MK-677: ~60% oral |
| Typical dose | Sema 0.25-2.4mg/wk + 5A1MQ 100mg 2x/day + MOTS-c 10mg 3x/wk + Tesa 2mg/day | CJC-1295 100mcg + Ipamorelin 200mcg + MK-677 25mg oral |
| Frequency | Variable by component | CJC/Ipa: nightly, MK-677: daily |
| Route | SC injection + Oral | Subcutaneous + Oral |
Apollo Stack reported benefits
- Dramatic fat loss
- Visceral fat reduction
- Metabolic rate increase
- Appetite control
- Improved insulin sensitivity
- Cellular energy boost
Superman Stack reported benefits
- Maximized GH output
- 24/7 GH/IGF-1 elevation
- Improved sleep quality
- Enhanced fat loss
- Increased muscle recovery
- Anti-aging effects
Related comparisons
Research and educational reference only. Not medical advice.